Responses
E-Poster Viewing Abstracts
AS10. Ovarian cancer
EV344/#770 Surufatinib combined with toripalimab for the treatment of recurrent ovarian clear cell carcinoma: a prospective single center, single-arm phase II clinical trial
Compose a Response to This Article
Other responses
No responses have been published for this article.